Targeting and Blockades of Advanced and Metastatic Breast Cancer with Trispecific or Dual Bispecific Antibodies Non-Covalently Bound on Mpegylated Nanocarriers Loaded with Docetaxel and Pictilisib for Synergistic Therapy and Circumventing the Resistance

Project: A - Government Institutionb - Ministry of Science and Technology

Project Details

Effective start/end date8/1/197/31/20


  • Trastuzumab
  • Pertuzumab
  • Pictilisib
  • Docetaxel
  • Anti-HER2IV/anti-mPEG Bispecific Antibody
  • Synergistic combination